Joseph K. Schachle - 27 Nov 2023 Form 3 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: Chief Operating Officer
Signature: /s/ Jessica Herron, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 27 Nov 2023
Net transactions value: $0
Form type: 3
Filing time: 27 Nov 2023, 18:19:26 UTC
Next filing: 25 Mar 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24, Power of Attorney, is attached.